BeiGene
The Latest
-
Nasdaq-Listed BeiGene To Be A Star On The Shanghai Board
The offering is expected in the first half of next year. It will be the world's first pharmaceutical firm to be listed on three stock exchanges. 
The offering is expected in the first half of next year. It will be the world's first pharmaceutical firm to be listed on three stock exchanges. -
Amgen Stake In Chinese Biotech Firm Valued At $13.5 Billion
BeiGene soared 25.6 percent in after-hours sessions, while Amgen settled 1.1 percent flat. 
BeiGene soared 25.6 percent in after-hours sessions, while Amgen settled 1.1 percent flat.
